Temazepam updated on 02-10-2025

Abdominal wall defects

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S15331
R63153		 Ban (Other indications) (Controls unexposed, disease free), 2014 Abdominal wall malformations 1st trimester retrospective cohort (claims database) unexposed, disease free excluded Adjustment: No BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) Indication BZD: Psychiatric diseases (depression, anxiety, ...) 11.35 [1.58;81.73] C
excluded (control group) 		1/379   82/351,785 83 379
ref
S15329
R63123		 Ban (Other indications) (Controls unexposed, sick), 2014 Abdominal wall malformations 1st trimester retrospective cohort (claims database) unexposed, sick Adjustment: No BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) Indication BZD: Psychiatric diseases (depression, anxiety, ...) 12.69 [1.42;113.82] C 1/379   4/19,193 5 379
ref
Total 1 studies 12.69 [1.42;113.82] 5 379
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Ban (Other indications) (Controls unexposed, sick), 2014Ban, 2014 1 12.69[1.42; 113.82]53790%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: moderateROB mesure: unclearROB reporting: moderate0.950.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Other indications) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 1 Tags Adjustment   - No  - No 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 1 BZD Coexposure   - No (among psychiatric (ATD and/or p ...  - No (among psychiatric (ATD and/or psychotropics) medications) 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 1 Indication BZD   - Psychiatric diseases (depression, a ...  - Psychiatric diseases (depression, anxiety, ...) 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 1 All studiesAll studies 12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 10.550.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 15331

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) Out of scale11.35[1.58; 81.73]83379 -NABan (Other indications) (Controls unexposed, disease free), 2014 1 unexposed, sick controlsunexposed, sick controls Out of scale12.69[1.42; 113.82]5379 -NABan (Other indications) (Controls unexposed, sick), 2014 10.510.01.0